Research Article
Serum-Based lncRNA ANRIL, TUG1, UCA1, and HIT Expressions in Breast Cancer Patients
Table 2
Long noncoding RNA-ARNILA expression and clinicopathological features.
| Variables | Long noncoding RNA-ANRIL | value | Mean | SD |
| Relative expression | 3.83 | 2.66 | — | Age | | | | ≤50 years | 3.90 | 2.95 | 0.90 | >50 years | 3.75 | 2.30 | Menopause | | | | Yes | 3.24 | 2.51 | 0.10 | No | 4.12 | 2.70 | Lymph nodes | | | | Yes | 3.31 | 2.31 | 0.04 | No | 4.50 | 2.94 | ER status | | | | Yes | 4.02 | 2.79 | 0.69 | No | 3.74 | 2.61 | PR status | | | | Yes | 4.89 | 3.52 | 0.04 | No | 3.42 | 2.13 | Her2 status | | | | Yes | 3.89 | 3.80 | 0.98 | No | 2.87 | 2.53 | TNM stages | | | | Early stage (I&II) | 3.26 | 2.12 | 0.12 | Advanced stage (III&IV) | 4.18 | 2.90 | Distant metastases | | | | Yes | 5.69 | 2.78 | <0.0001 | No | 3.25 | 2.35 |
|
|